| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.9467 | 32 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.025 | 27 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.6465 | 20 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.0081 | 48 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.5921 | 39 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.1079 | 23 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 48.538 | 43 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.6593 | 40 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.1448 | 33 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.8248 | 36 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.0583 | 32 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.9909 | 48 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.1456 | 49 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.279 | 28 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.7889 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.3592 | 43 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.1337 | 23 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.5079 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.3592 | 24 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.501 | 20 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.3986 | 24 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.7119 | 21 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.1749 | 18 |